Announcements

Intimation about Board Meeting scheduled to be held on Saturday, May 8, 2021, inter alia, to consider and approve the audited financial results (both Stand-alone and Consolidated) for the year ended 31st March 2021, to consider recommending final dividend, if any, for the financial year 2020-21, and to consider granting of stock options to employees for 2020-21.

Intimation of business update about increased turnover in Q4, enhancement on the RT-PCR testing capacity of laboratories at Navi Mumbai & Gurgaon, approval of the Covid testing facility in Bangalore by NABL, completion of more than one million Covid tests as on 31-03-2021, etc. View Here

Intimation that Trading Window shall remain closed for Directors / Designated Employees / Connected Persons with effect from 1^st April, 2021, and would be re-opened after 48 hours of date of announcement / declaration of Audited Financial Results for the Year ended March 31, 2021.

Intimation about the Con-call with the representative(s) of First State Sentier, at 09.00 A.M. on Monday, March 08, 2021.

Intimation about Transcript of the Earnings Call held on Thursday, February 04, 2021 at 05.00 P.M. local time of Indian and Overseas Investors, post declaration of the Company’s Unaudited Financial Results (stand-alone & consolidated) for the Quarter / Nine Months ended 31-12-2020. Click here

Intimation about the con-calls with the representatives of the following organizations:

(i) Mirabilis Investment Trust, at 05.00 P.M. on Monday, February 15, 2021.

(ii) Arisaig Partners, at 03.00 P.M. on Friday, February 19, 2021.

Intimation about conference call for Indian and Overseas Investors to be held on Thursday, February 04, 2021 to discuss about Unaudited financial results (Stand-alone and Consolidated) for the quarter / nine months ended 31-12-2020. Click here to see the invite

Intimation of outcome of the Board Meeting held on January 30, 2021, as follows:

1) The Board approved Unaudited Financial Results (both Stand-alone and Consolidated) for the quarter / Nine Months ended 31-12-2020.

2) The Board decided to defer the question of further dividend to the next meeting.

3) With regard to appointment of new Auditors, the Board authorized Dr. A. Velumani, Chairman & Managing Director, Mr. A. Sundararaju, Executive Director & CFO and Mr. G.S. Hegde, Independent Director, to take a decision and report to the Committee / Board at the earliest.

Intimation about Board Meeting scheduled to be held on Saturday, January 30, 2021, inter alia, to consider and approve the unaudited financial results (both Stand-alone and Consolidated) for the quarter / nine months ended 31st December, 2020, to consider and decide on payment of further interim dividend, if any, for the financial year 2020-21, and to consider appointment of new auditors in the place of current auditors whose term would expire shortly.

Intimation about (1) significant business revival in Q3 of the current financial year, after business activities resumed across all states, and the growth in the non-covid business and (2) increase in volume of RT-PCR tests making us most cost effective service provider to the patients. View Here

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1^st January, 2021 and will be reopened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the quarter / nine months ended December 31, 2020.

Intimation regarding allotment of 38054 Equity Shares to 135 eligible employees after obtaining required approvals from Stock Exchanges.

Intimation about the Con-call with the representative(s) of Grandeur Peak Global Advisors, at 10.00 A.M. on Tuesday, December 08, 2020.

Intimation about the Con-call with the representative(s) of Wellington Management Hong Kong Ltd., at 11.30 A.M. on Tuesday, November 24, 2020.

Intimation about the Con-call (Zoom Meeting) with the representative(s) of Arisaig Partners, at 05.00 P.M. today, i.e. on Tuesday, November 10, 2020.

Intimation about Transcript of the Earnings Call held on Tuesday, November 03, 2020 at 12.00 Noon local time of Indian and Overseas Investors, post declaration of the Company’s Unaudited Financial Results (stand-alone & consolidated) for the Quarter / Half Year ended 30-09-2020. Click here

Intimation about conference call for Indian and Overseas Investors to be held on Tuesday, November 03, 2020 to discuss about Unaudited financial results (Stand-alone and Consolidated) for the quarter / half year ended 30-09-2020. Click here to see the invite

Intimation of outcome of the Board Meeting held on October 28, 2020, as follows:

1) The Board approved Unaudited Financial Results (both Stand-alone and Consolidated) for the quarter / half year ended on 30-09-2020.

2) The Board declared an interim dividend of Rs.10/- per share for FY 2020-21.

3) The Board took on record the following changes of the Key Managerial Personnel:

i. Dr. A. Velumani, Chairman, has been reappointed as Managing Director

ii. Mr. A. Sundararaju, has been reappointed as Executive Director & Chief Financial Officer

iii. Mr. Arindam Haldar has been appointed as Chief Executive Officer.

Intimation about Board Meeting scheduled to be held on Wednesday, October 28, 2020, inter alia, to consider and approve the unaudited financial results (both Stand-alone and Consolidated) for the quarter / half year ended 30th September 2020, and to consider and decide on payment of interim dividend, if any, for the financial year 2020-21.

Intimation regarding business update on COVID-19 RT-PCR tests and COVID Antibody tests as on September 30, 2020.  The Company has also started RT-PCR tests from  its Laboratory situated at Gurgaon, Delhi and will create the same kind of facilities at Banglore and Kolkata. View Here

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1^st October, 2020 and will be reopened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the quarter and half year ended September 30, 2020.

Intimation about the con-calls with the representatives of the following organizations:

(i) Nomura Asset Management Singapore Ltd., at 11.00 A.M. on Wednesday, September 23, 2020.

(ii) Acacia Partners, at 03.30 P.M. on Wednesday, September 23, 2020.

(iii) Earnest Innovation Partners Pvt. Ltd., at 11.00 A.M. on Thursday, September 24, 2020.

(iv) Abakkus Asset Manager LLP, at 03.30 P.M. on Thursday, September 24, 2020.

Intimation regarding appointment of Mr. Arindam Haldar as Chief Executive Officer (CEO) of the Company w.e.f. September 14, 2020. View Here

Intimation of decisions taken at the Board Meeting held on September 10, 2020, authorizing Dr. A. Velumani, Chairman & Managing Director, to identify and appoint a suitable candidate as a professional Chief Executive Officer for the Company. The Board also authorized Dr. A. Velumani, Chairman, to identify competent candidates for the positions of Managing Director, Executive Director, and other senior positions at his discretion.

Intimation about the Con-call (Zoom Meeting) with the representative(s) of Arisaig Partners, at 05.30 P.M. on Thursday, September 10, 2020.

Intimation about (i) 20th Annual General Meeting convened to be held on Tuesday, September 29, 2020 at 3.00 P.M. through Video Conferencing (VC) / Other Audio Visual Means (OAVM) & (ii) E-voting facility available to the Shareholders prior to the AGM and during the AGM.

Intimation about the Con-call with the representative(s) of Sylebra Capital Limited, at 11.30 A.M. on Monday, September 07, 2020.

Intimation about Board Meeting scheduled to be held on Thursday, September 10, 2020, inter alia, to discuss and decide about appointing a professional Chief Executive Officer of the Company who will function under the superintendence of the Board of Directors of the Company, headed by Dr. A. Velumani, PhD, Chairman & Managing Director.

Intimation of decisions taken at the Board Meeting held on July 31, 2020, about (i) approval of the Unaudited Financial Results (both Stand-alone and Consolidated) for the quarter ended on 30-06-2020, and (ii) decision not to declare any Interim Dividend considering the prevailing uncertain economic scenario.

Intimation about Board Meeting scheduled to be held on Friday, July 31, 2020, inter alia, to consider and approve the unaudited financial results (both Stand-alone and Consolidated) for the quarter ended 30th June 2020, and to consider and decide on payment of interim dividend, if any, for the financial year 2020-21.